Biotech · Private company · San Diego, CA, US
Tracon Pharmaceuticals, Inc.
SEC CIK 0001394319
Track this companyFree. Adds Tracon Pharmaceuticals, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials160 recruiting or active
Pipeline programs31From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline31
- TRC105Phase 3 · Advanced AngiosarcomaClinicalTrials.gov · fetched Nov 12, 2026
- VotrientPhase 3 · Advanced AngiosarcomaClinicalTrials.gov · fetched Nov 12, 2026
- AxitinibPhase 2 · Renal Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- BevacizumabPhase 2 · GlioblastomaClinicalTrials.gov · fetched Nov 12, 2026
- BevacizumabPhase 2 · ChoriocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- BevacizumabPhase 2 · Gestational Trophoblastic NeoplasiaClinicalTrials.gov · fetched Nov 12, 2026
- CapecitabinePhase 2 · Metastatic Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- Carotuximab (TRC105)Phase 2 · Hepatocellular CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- Carotuximab (TRC105)Phase 2 · Recurrent Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
- DoxorubicinPhase 2 · Advanced SarcomaClinicalTrials.gov · fetched Nov 12, 2026
- EnvafolimabPhase 2 · Advanced SarcomaClinicalTrials.gov · fetched Nov 12, 2026
- EnvafolimabPhase 2 · Undifferentiated Pleomorphic SarcomaClinicalTrials.gov · fetched Nov 12, 2026
- IpilimumabPhase 2 · Undifferentiated Pleomorphic SarcomaClinicalTrials.gov · fetched Nov 12, 2026
- SorafenibPhase 2 · Hepatocellular CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- TRC105Phase 2 · ChoriocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- TRC105Phase 2 · Metastatic Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- TRC105Phase 2 · GlioblastomaClinicalTrials.gov · fetched Nov 12, 2026
- TRC105Phase 2 · Gestational Trophoblastic NeoplasiaClinicalTrials.gov · fetched Nov 12, 2026
- TRC105 and AxitinibPhase 2 · Renal Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- TRC105 and PazopanibPhase 2 · Advanced Soft Tissue SarcomaClinicalTrials.gov · fetched Nov 12, 2026
- TRC253Phase 2 · Metastatic Castrate-resistant Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- YH001Phase 2 · Advanced SarcomaClinicalTrials.gov · fetched Nov 12, 2026
- AtezolizumabPhase 1 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- Carotuximab (TRC105)Phase 1 · Carcinoma, Non-Small-Cell LungClinicalTrials.gov · fetched Nov 12, 2026
- OPDIVOPhase 1 · Carcinoma, Non-Small-Cell LungClinicalTrials.gov · fetched Nov 12, 2026
- TJ004309Phase 1 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- AxitinibSolid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- BevacizumabSolid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- CapecitabineSolid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- PazopanibSolid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- TRC105Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials16
- YH001 Plus Envafolimab With or Without Doxorubicin in Patients With Advanced or Metastatic SarcomaPHASE1_PHASE2 · UNKNOWN · started Nov 14, 2022ClinicalTrials.gov NCT05448820 · fetched Nov 12, 2026
- ENVASARC: Envafolimab And Envafolimab With Ipilimumab In Patients With Undifferentiated Pleomorphic Sarcoma Or MyxofibrosarcomaPHASE2 · UNKNOWN · started Dec 9, 2020ClinicalTrials.gov NCT04480502 · fetched Nov 12, 2026
- Study of TJ004309 in Combination With Atezolizumab (Tecentriq®) in Patients With Advanced or Metastatic CancerPHASE1 · UNKNOWN · started Jul 16, 2019ClinicalTrials.gov NCT03835949 · fetched Nov 12, 2026
- Study of Carotuximab (TRC105) Plus Nivolumab in Patients With Metastatic NSCLCPHASE1 · COMPLETED · started Nov 9, 2017ClinicalTrials.gov NCT03181308 · fetched Nov 12, 2026
- Phase 1/2A Study of TRC253, an Androgen Receptor Antagonist, in Metastatic Castration-resistant Prostate Cancer PatientsPHASE1_PHASE2 · COMPLETED · started May 23, 2017ClinicalTrials.gov NCT02987829 · fetched Nov 12, 2026
- Trial of TRC105 and Pazopanib Versus Pazopanib Alone in Patients With Advanced AngiosarcomaPHASE3 · COMPLETED · started Feb 13, 2017ClinicalTrials.gov NCT02979899 · fetched Nov 12, 2026
- Trial of TRC105 and Sorafenib in Patients With HCCPHASE1_PHASE2 · COMPLETED · started Nov 1, 2016ClinicalTrials.gov NCT02560779 · fetched Nov 12, 2026
- Study of TRC105 and Bevacizumab in Patients With Refractory Gestational Trophoblastic Neoplasia (GTN)PHASE2 · TERMINATED · started Mar 1, 2016ClinicalTrials.gov NCT02664961 · fetched Nov 12, 2026
- Combination of Letrozole, Everolimus and TRC105 in Postmenopausal Women With Hormone-Receptor Positive and Her2 Negative Breast CancerPHASE1_PHASE2 · COMPLETED · started Feb 1, 2015ClinicalTrials.gov NCT02520063 · fetched Nov 12, 2026
- TRC105 Combined With Standard-dose Bevacizumab for Two Patients With Metastatic And Refractory ChoriocarcinomaPHASE2 · COMPLETED · started Jan 1, 2015ClinicalTrials.gov NCT02396511 · fetched Nov 12, 2026
- A Phase 1B Dose-escalation and Phase 2a Study of Carotuximab (TRC105) in Combination With Pazopanib in Patients With Advanced Soft Tissue SarcomaPHASE1_PHASE2 · COMPLETED · started Dec 10, 2013ClinicalTrials.gov NCT01975519 · fetched Nov 12, 2026
- Randomized Phase 2 Trial of Axitinib and TRC105 Versus Axitinib Alone in Patients Renal Cell CarcinomaPHASE1_PHASE2 · TERMINATED · started Mar 8, 2013ClinicalTrials.gov NCT01806064 · fetched Nov 12, 2026
- A Phase 2 Evaluation of TRC105 In Combination With Bevacizumab in Patients With GlioblastomaPHASE2 · COMPLETED · started May 1, 2012ClinicalTrials.gov NCT01564914 · fetched Nov 12, 2026
- Evaluation of TRC105 in the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal CarcinomaPHASE2 · COMPLETED · started Jul 1, 2011ClinicalTrials.gov NCT01381861 · fetched Nov 12, 2026
- Open Label Dose-Finding Study of TRC105 Plus Capecitabine for Metastatic Breast CancerPHASE1_PHASE2 · COMPLETED · started Jun 1, 2011ClinicalTrials.gov NCT01326481 · fetched Nov 12, 2026
- Open Label Continuation Study of TRC105 for Patients Who Have Completed a Prior TRC105 TrialNO_LONGER_AVAILABLEClinicalTrials.gov NCT02354612 · fetched Nov 12, 2026